84 related articles for article (PubMed ID: 36386799)
1. A cuproptosis-based prognostic model for predicting survival in low-grade glioma.
Zhao Z; Ma Y; Liu Y; Chen Z; Zheng J
Aging (Albany NY); 2024 May; 16():. PubMed ID: 38738989
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of necroptosis related gene signature to predict clinical outcomes, immune status and drug sensitivity in lower grade Glioma.
Hu X; Ma Y; Xia Y; Liu B
Heliyon; 2024 Jan; 10(1):e23947. PubMed ID: 38192784
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of the cuproptosis-related gene ATP7B in the prognosis and immune infiltration of IDH1 wild-type glioma.
Zhang K; Qu C; Zhou P; Yang Z; Wu X
Gene; 2024 May; 905():148220. PubMed ID: 38286269
[TBL] [Abstract][Full Text] [Related]
4. Copper Homeostasis Based on Cuproptosis-Related Signature Optimizes Molecular Subtyping and Treatment of Glioma.
Zhang S; Yu H; Sun S; Fan X; Bi W; Li S; Wang W; Fang Z; Chen X
Mol Neurobiol; 2023 Dec; ():. PubMed ID: 38151613
[TBL] [Abstract][Full Text] [Related]
5. Novel immune checkpoint-related gene model to predict prognosis and treatment responsiveness in low-grade gliomas.
Guo Y; Bao J; Lin D; Hong K; Cen K; Sun J; Wang Z; Wu Z
Heliyon; 2023 Sep; 9(9):e20178. PubMed ID: 37809899
[TBL] [Abstract][Full Text] [Related]
6. Integrating Machine Learning and Mendelian Randomization Determined a Functional Neurotrophin-Related Gene Signature in Patients with Lower-Grade Glioma.
Zhang C; Lai G; Deng J; Li K; Chen L; Zhong X; Xie B
Mol Biotechnol; 2024 Jan; ():. PubMed ID: 38261152
[TBL] [Abstract][Full Text] [Related]
7. A novel gene signature based on five immune checkpoint genes predicts the survival of glioma.
Zhang W; Zhai Y; Li G; Jiang T
Chin Neurosurg J; 2021 Feb; 7(1):15. PubMed ID: 33531060
[TBL] [Abstract][Full Text] [Related]
8. Establishment and analysis of artificial neural network diagnosis model for coagulation-related molecular subgroups in coronary artery disease.
Zheng B; Li Y; Xiong G
Front Genet; 2024; 15():1351774. PubMed ID: 38495669
[No Abstract] [Full Text] [Related]
9. A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas.
Zhu H; Wan Q; Tan J; Ouyang H; Pan X; Li M; Zhao Y
Front Genet; 2022; 13():992995. PubMed ID: 36579333
[No Abstract] [Full Text] [Related]
10. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma.
Wen J; Zhao W; Shu X
Front Oncol; 2022; 12():1087762. PubMed ID: 36776374
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cuproptosis-related genes in prognosis and immune infiltration in grade 4 diffuse gliomas.
Liu H; Bao X; Zeng Z; Liu W; Li M
Heliyon; 2024 Apr; 10(7):e29212. PubMed ID: 38633656
[TBL] [Abstract][Full Text] [Related]
12. Immune-related gene signature to predict TACE refractoriness in patients with hepatocellular carcinoma based on artificial neural network.
Xu Q; Wang C; Yin G
Front Genet; 2022; 13():993509. PubMed ID: 36685822
[No Abstract] [Full Text] [Related]
13. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
Front Immunol; 2022; 13():933973. PubMed ID: 36045691
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas.
Huang H; Lv Z; Yang L; Zhang X; Deng Y; Huang Z; Bi H; Sun X; Zhang M; Hu D; Liang H; Hu F
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11499-11515. PubMed ID: 37392200
[TBL] [Abstract][Full Text] [Related]
15. Cuproptosis-related gene-located DNA methylation in lower-grade glioma: Prognosis and tumor microenvironment.
Zhu L; Yuan F; Wang X; Zhu R; Guo W
Cancer Biomark; 2024 Mar; ():. PubMed ID: 38578883
[TBL] [Abstract][Full Text] [Related]
16. Novel Cuproptosis-Related Gene Signature for Precise Identification of High-Risk Populations in Low-Grade Gliomas.
Chen P; Han H; Wang X; Wang B; Wang Z
Mediators Inflamm; 2023; 2023():6232620. PubMed ID: 36814682
[TBL] [Abstract][Full Text] [Related]
17. Machine learning algorithm to construct cuproptosis- and immune-related prognosis prediction model for colon cancer.
Huang YY; Bao TY; Huang XQ; Lan QW; Huang ZM; Chen YH; Hu ZD; Guo XG
World J Gastrointest Oncol; 2023 Mar; 15(3):372-388. PubMed ID: 37009317
[TBL] [Abstract][Full Text] [Related]
18. Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics.
Zhang Z; Wang B; Xu X; Xin T
Front Genet; 2022; 13():1036460. PubMed ID: 36386799
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
